검색

검색할 검색어를 입력해 주세요.
통합검색 보도자료 사진 동영상 기업 박람회 블로그 페이지 FAQ
보도자료
»
Hinda Gharbi, CEO Bureau Veritas
7월 25일 18:07
Bureau Veritas: Robust Organic Revenue Growth and Strong Margin Increase in H1 2025 as the LEAP | 28 Strategy Execution Accelerates; Confirmed 2025 Outlook
Bureau Veritas (BOURSE:BVI): H1 2025 key figures[1] › Revenue of EUR 3,192.5 million in the first half of 2025, up 5.7% year-on-year and up 6.7% organically (with 6.2% organic growth in Q2 2025), › Adjusted operating profit of EUR 491.5 million, up 8.8% versus EUR 451.9 million in H1 2024, represent...
Hinda Gharbi, CEO Bureau Veritas (Photo: Business Wire)
2월 25일 17:15
Bureau Veritas' LEAP | 28 Strategy Delivers Outstanding Results in 2024; Confident 2025 Outlook
Bureau Veritas (BOURSE:BVI): 2024 key figures[1] › Revenue of EUR 6,240.9 million in the full year 2024, up 6.4% year-on-year and up 10.2% organically (including 9.6% in the fourth quarter), › Adjusted operating profit of EUR 996.2 million, up 7.1% versus EUR 930.2 million in 2023, representing an a...
2024년 7월 26일 15:22
Bureau Veritas: Early Impact of the New LEAP | 28 Strategy Boosting Revenue and Improving Margins1 in the First Half; 2024 Revenue Outlook Upgraded
Hinda Gharbi, Chief Executive Officer, commented: “In the first half of the year, we kick started the execution of our LEAP I 28 strategy which was launched at the end of March 2024. Our H1 results confirm our commitment to a step change in growth and returns with organic growth of 9.2%, a solid org...
Skylla technologies, Boston Office - Chairman Boo-Ho Yang & Engineers
2024년 7월 22일 13:18
Movensys Wins Korean Government Contract to Develop AI-based Integrated Control Platform for Autonomous Mobile Robots
Movensys today announced that it has been awarded a national government contract as part of a consortium to develop an integrated platform that leverages AI to improve the accuracy and compatibility of autonomous mobile robot (AMR) control software. A consortium comprised of Movensys, its U.S. subsi...
2021년 11월 17일 09:06
Icure Acquires Drug Product Approval for World’s First Donepezil Patch for Treating Dementia of the Alzheimer Type in Korea
Icure Pharmaceutical Inc. (KOSDAQ: 175250), a biopharmaceutical company in Korea, announced today that its donepezil patch, a treatment of Alzheimer’s-type dementia, received a drug product approval from the Ministry of Food and Drug Safety of Korea. The drug product approval process took 7 months a...
9개 보도자료 보기